Therefore, testing vaccine excipients may be useful for detecting those who, with a personal history highly compatible with PEG/PS allergy, have developed a specific IgE reactivity, to address the consequent decision-making and estimate the risks of other possible PEG/PS exposures [20]. Here, IGHE is linked to allergic disease.